REG - Inspecs Group PLC - Change to Publication Date of Results

InspecsAnnouncement

17/05/2022 17:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220517:nRSQ8463La&default-theme=true

RNS Number : 8463L  Inspecs Group PLC  17 May 2022

17 May 2022

 

Inspecs Group plc

("Inspecs" or "the Group")

 

Change to Publication Date of Results

 

Inspecs Group plc, a leading designer, manufacturer and distributor of eyewear
(sunglasses, optical frames and lenses) announces that its Final Results for
the year ended 31 December 2021 will no longer be published on 19 May 2022 as
previously announced. This delay is caused by an accounting issue in relation
to a subsidiary company in the United States that was acquired in December
2020. This accounting issue is a non-cash item, is not expected to be material
in the context of the Group's assets, and is currently being reviewed and
finalised by both the Company and its auditors. It is expected that Group's
Final Results will be published by mid-June 2022. Inspecs will update the
market with a release date closer to the time.

 

For further information please contact:

 

 Inspecs Group plc                         via FTI Consulting

 Robin Totterman (CEO)                     Tel: +44 (0) 20 3727 1000

 Chris Kay (CFO)

 Peel Hunt (Nominated Adviser and Broker)  Tel: +44 (0) 20 7418 8900

 Adrian Trimmings

 Andrew Clark

 Lalit Bose

 FTI Consulting (Financial PR)             Tel: +44 (0) 20 3727 1000

 Alex Beagley

 Alice Newlyn

 Harriet Jackson

This announcement contains inside information within the meaning of the Market
Abuse Regulation. The person responsible for arranging release of this
announcement on behalf of Inspecs in Chris Kay, Chief Financial Officer.

 

About Inspecs Group plc

 

INSPECS is a Bath-based designer, manufacturer and distributor of eyewear
frames and optically advanced spectacle lenses. The Group produces a broad
range of frames and lenses, covering optical, sunglasses and safety, which are
either "Branded" (either under licence or under the Group's own proprietary
brands), or "OEM" (including private label on behalf of retail customers and
un-branded).

INSPECS aims to be the leader in eyewear solutions through its
vertically-integrated business model and has adopted a three pillar growth
strategy to achieve this: (i) continue to grow organically; (ii) undertake
further acquisitions (and drive value through leveraging the Group's internal
capabilities); and (iii) extend the Group's manufacturing capacity.

 

The Group has completed a number of significant acquisitions since its IPO in
February 2020. In December 2020, INSPECS acquired Eschenbach, a leading,
global, eyewear supplier headquartered in Nuremberg, Germany, which includes
the American company Tura. This followed the acquisition of lens maker
Norville in July 2020, whereby INSPECS combined two heritage brands in British
optical, Savile Row frame maker, and Norville lens maker, further enhancing
its vertically integrated business model. In December 2021 the Group acquired
Ego Eyewear, a design and licensing company which uses third party eyewear
manufacturers to produce premium fashion brands, and BoDe, a distributor of
optical and sunglasses frames principally to the German market.

 

INSPECS customers include global optical and non-optical retailers, global
distributors and independent opticians, with its distribution network covering
over 80 countries and reaching approximately 75,000 points of sale.

 

INSPECS has operations across the globe: with offices in the UK, Portugal,
Scandinavia, the US and China (Hong Kong, Macau and Shenzhen), and
manufacturing facilities in Vietnam, China, the UK and Italy. With the
acquisition of Eschenbach, the Group's international reach further extends
across Europe and the American markets.

 

More information is available at: https://inspecs.com (https://inspecs.com)
 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORQDLFFLELXBBK